Patents by Inventor Kristen King

Kristen King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190314272
    Abstract: The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a liquid formulation of a humanised anti-NGF antibody.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 17, 2019
    Inventors: Advait Vijay Badkar, Leigh Kristen Bohack, Kevin Roger King, Atlanta Lea Lary
  • Patent number: 8790391
    Abstract: The present disclosure pertains to stents having a coating applied thereto, wherein the coating comprises a biocompatible polymer/drug mixture, as well as devices comprising a metallic stent, a biocompatible polymeric carrier and a drug.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: July 29, 2014
    Assignee: Cordis Corporation
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King, Robert Falotico
  • Publication number: 20120172976
    Abstract: The present disclosure pertains to stents having a coating applied thereto, wherein the coating comprises a biocompatible polymer/drug mixture, as well as devices comprising a metallic stent, a biocompatible polymeric carrier and a drug.
    Type: Application
    Filed: March 15, 2012
    Publication date: July 5, 2012
    Applicant: CORDIS CORPORATION
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Publication number: 20100239636
    Abstract: Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel.
    Type: Application
    Filed: June 2, 2010
    Publication date: September 23, 2010
    Applicant: CORDIS CORPORATION
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Patent number: 7666222
    Abstract: Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: February 23, 2010
    Assignee: Cordis Corporation
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Publication number: 20080317827
    Abstract: Methods of preparing devices for delivering at least one therapeutic agent to a target vessel in a mammal, the devices prepared by such methods, and uses of such devices for delivering a therapeutic agent, such as an antiproliferative agent, to a target vessel.
    Type: Application
    Filed: September 5, 2008
    Publication date: December 25, 2008
    Applicant: CORDIS CORPORATION
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Publication number: 20070100436
    Abstract: Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
    Type: Application
    Filed: November 1, 2006
    Publication date: May 3, 2007
    Applicant: Cordis Corporation
    Inventors: Carol Wright, Gerard Llanos, Ronald Rakos, Kristen King
  • Publication number: 20070021825
    Abstract: Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
    Type: Application
    Filed: August 24, 2006
    Publication date: January 25, 2007
    Applicant: Cordis Corporation
    Inventors: Carol Wright, Gerard Llanos, Ronald Rakos, Kristen King
  • Publication number: 20060282160
    Abstract: Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
    Type: Application
    Filed: August 24, 2006
    Publication date: December 14, 2006
    Applicant: Cordis Corporation
    Inventors: Carol Wright, Gerard Llanos, Ronald Rakos, Kristen King
  • Publication number: 20050085902
    Abstract: Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis.
    Type: Application
    Filed: September 28, 2004
    Publication date: April 21, 2005
    Inventors: Carol Wright, Gerard Llanos, Ronald Rakos, Kristen King
  • Patent number: 6808536
    Abstract: Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
    Type: Grant
    Filed: April 7, 2003
    Date of Patent: October 26, 2004
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Publication number: 20030176915
    Abstract: Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
    Type: Application
    Filed: April 7, 2003
    Publication date: September 18, 2003
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Patent number: 6585764
    Abstract: Delivery of rapamycin locally, particularly from intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
    Type: Grant
    Filed: June 4, 2001
    Date of Patent: July 1, 2003
    Assignee: Cordis Corporation
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Publication number: 20010027340
    Abstract: Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
    Type: Application
    Filed: June 4, 2001
    Publication date: October 4, 2001
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King
  • Patent number: 6273913
    Abstract: Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
    Type: Grant
    Filed: April 16, 1998
    Date of Patent: August 14, 2001
    Assignee: Cordis Corporation
    Inventors: Carol Wright, Gerard H. Llanos, Ronald Rakos, Kristen King